While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...

In the past, Parkinson’s disease was primarily considered a disorder of the nervous system, centered in the brain. However, ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

2024 — A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's disease (PD ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

A new treatment is now available for people who have certain Parkinson’s Disease symptoms including medication-resistant ...

Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making ... are detected in blood once symptoms have started in Lewy's body diseases, ... July 23, 2024 — Researchers ...